Health and Racial Disparity in Breast Cancer.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or primary human data
PubMed 31456178 · doi:10.1007/978-3-030-20301-6_3
What was done
This narrative review and book chapter synthesized epidemiological trends and literature to summarize differences in breast cancer incidence, mortality, risk factors, genetics, and treatment outcomes among racial and ethnic groups, focusing primarily on non-Hispanic White, non-Hispanic Black, and Hispanic populations in the United States.
What was found
The abstract reports that female lifetime risk of breast cancer increased from 1 in 11 in 1975 to 1 in 8, with risk rising with age. While breast cancer mortality decreased among White women due to earlier detection and better treatments, cancer incidence has grown among African American and Hispanic populations, with African Americans experiencing comparatively limited survival benefits from existing treatment strategies. No additional numerical data or effect sizes are provided in the abstract.
Why it matters
It highlights persistent racial inequities in breast cancer survival and treatment benefit despite overall therapeutic progress, emphasizing the need for targeted strategies and diverse research leadership.
Limits
As a narrative review, it presents no original data or systematic search protocol. The abstract contains few quantitative metrics and does not detail specific cohorts, sample sizes, or effect estimates.
Cited by
- supports A woman's lifetime risk of developing breast cancer is approximately 1 in 8.